NP47725a Emicizumab (Indication Specific)

A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source: Find a Tender
Type: Framework (Supply)
Duration: not specified
Value: £3M

Sector: HEALTH
Published: 18 Sep 2025
Delivery: not specified
Deadline: n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 1 suppliers

2 buyers

NHS National Services Scotland NSS Edinburgh

1 supplier

Roche Products Welwyn Garden City

Description

Supply of Emicizumab (Indication Specific) to NHS Scotland.

Total Quantity or Scope

The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Award Detail

1	Roche Products (Welwyn Garden City) Value: £3,120,312

CPV Codes

33600000 - Pharmaceutical products

Indicators

Legal Justification

Competition for some of the medicines awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015. Some of the medicines awarded to the Framework Agreement are protected by exclusive rights, including intellectual property rights, in accordance with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.